Thought Leadership
At NDA our experts stay abreast with the evolving environment and the new regulatory requirements that it gives rise to. One of the results of these activities is a stream of articles, commentaries and white papers that we publish for the benefit of our clients and followers. It captures the state of the art of our industry today.
We call it Thought Leadership.
Articles and White Papers
Service:
Scientific:
Sort by:
All services
Development Strategy
Medical Devices
Pharmacovigilance
NDA Advisory Board
Strategic Communications
Regulatory
Quality & Compliance
All expertise
Oncology
Vaccine
Immunogenicity
HTA
In-Vitro Diagnostics
Non-Clinical
Cell and Gene Therapy
Biostatistics
Cardiology
ATMP
Rare Disease
Market Access
CMC
Clinical
Paediatric
Acceleration Strategies
Medical Devices
Quality
Patient Safety
18-03-2021
NDA Webinars Medical Device Regulation: Session 5
In the fifth session in our MDR seminar series, Dr Tina Amini walks you through the Post Market Surveillance (PMS) requirements under the EU MDR
09-03-2021
NDA Webinars Medical Device Regulation: Session 4
In the fourth session in our MDR seminar series, Dr Tina Amini walks you through the clinical evaluation of Medical Devices.
19-02-2021
NDA Webinars Medical Device Regulation: Session 3
In the third session in our MDR seminar series, Dr Tina Amini walks you through the details of the impact of EU MDR on Drug/Device Combination Products (DDCs).
05-02-2021
NDA Webinars Medical Device Regulation: Session 2
In the second session in our MDR seminar series, Dr Tina Amini walks you through the details of the MDR requirements when it comes to QMS and the necessary steps to ensure compliance with MDR requirements.
28-01-2021
NDA Webinars Medical Device Regulation: Session 1
In the first session of our webinar series Dr Tina Amini, Medical Device Division Director at NDA presents an introduction to MDR and the key changes
02-04-2020
New EU In vitro Diagnostics Regulation (IVDR) and Companion Diagnostics
The companion diagnostics market is an emerging market and is anticipated to experience significant growth owing to increase in targeted therapies, rise in demand for personalised medicine with increase in awareness in emerging economies, discovery of n...